Khiron Life Sciences Corp.

Khiron Life Sciences Corp. is a Canada-based medical cannabis company specializing in the cultivation, production, and distribution of both low and high tetrahydrocannabinol (THC) medical cannabis, with a primary focus on Latin America and select European markets. The company is licensed in Colombia for domestic and international activities and operates through distinct business units including health services and medical cannabis products. Khiron’s integrated approach combines wholly-owned medical health clinics and exclusive telemedicine platforms to deliver patient-centered care, physician education, and innovative product solutions. Its medical clinics—operating under brands like ILANS and Zerenia—emphasize accessibility and physician-led services, contributing to the growth of medical cannabis prescriptions and brand loyalty among patients. In addition to core cannabis products, the company offers CBD-based cosmeceutical products under the Kuida brand. Headquartered in Vancouver, Khiron’s multidisciplinary leadership leverages expertise across Latin America and Europe, positioning the company as a specialist in alternative medicine and pharmaceuticals within emerging global markets.